OneMedNet (ONMD) Competitors $1.06 -0.01 (-0.93%) Closing price 04:00 PM EasternExtended Trading$0.98 -0.08 (-7.17%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ONMD vs. MXCT, HQI, ASPS, SKLZ, TDIC, CTW, XBP, RSSS, ARAI, and AMWLShould you be buying OneMedNet stock or one of its competitors? The main competitors of OneMedNet include MaxCyte (MXCT), HireQuest (HQI), Altisource Portfolio Solutions (ASPS), Skillz (SKLZ), Dreamland (TDIC), CTW Cayman (CTW), XBP Global (XBP), Research Solutions (RSSS), Arrive AI (ARAI), and American Well (AMWL). These companies are all part of the "business services" industry. OneMedNet vs. Its Competitors MaxCyte HireQuest Altisource Portfolio Solutions Skillz Dreamland CTW Cayman XBP Global Research Solutions Arrive AI American Well OneMedNet (NASDAQ:ONMD) and MaxCyte (NASDAQ:MXCT) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations. Is ONMD or MXCT more profitable? MaxCyte has a net margin of -125.22% compared to OneMedNet's net margin of -728.70%. OneMedNet's return on equity of 0.00% beat MaxCyte's return on equity.Company Net Margins Return on Equity Return on Assets OneMedNet-728.70% N/A -255.78% MaxCyte -125.22%-22.12%-19.10% Do institutionals and insiders hold more shares of ONMD or MXCT? 0.9% of OneMedNet shares are owned by institutional investors. Comparatively, 68.8% of MaxCyte shares are owned by institutional investors. 44.7% of OneMedNet shares are owned by company insiders. Comparatively, 3.3% of MaxCyte shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media prefer ONMD or MXCT? In the previous week, MaxCyte had 2 more articles in the media than OneMedNet. MarketBeat recorded 5 mentions for MaxCyte and 3 mentions for OneMedNet. OneMedNet's average media sentiment score of 1.30 beat MaxCyte's score of 0.72 indicating that OneMedNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OneMedNet 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MaxCyte 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, ONMD or MXCT? OneMedNet has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500. Comparatively, MaxCyte has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Do analysts prefer ONMD or MXCT? MaxCyte has a consensus price target of $7.00, suggesting a potential upside of 357.52%. Given MaxCyte's stronger consensus rating and higher possible upside, analysts plainly believe MaxCyte is more favorable than OneMedNet.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OneMedNet 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00MaxCyte 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has better valuation & earnings, ONMD or MXCT? OneMedNet has higher earnings, but lower revenue than MaxCyte. OneMedNet is trading at a lower price-to-earnings ratio than MaxCyte, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOneMedNet$459K106.45-$10.13M-$0.11-9.64MaxCyte$38.63M4.22-$41.06M-$0.43-3.56 SummaryMaxCyte beats OneMedNet on 10 of the 16 factors compared between the two stocks. Get OneMedNet News Delivered to You Automatically Sign up to receive the latest news and ratings for ONMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ONMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONMD vs. The Competition Export to ExcelMetricOneMedNetINTERNET SOFTWARE IndustryComputer SectorNASDAQ ExchangeMarket Cap$48.86M$19.72B$31.81B$10.37BDividend YieldN/A3.54%3.17%4.64%P/E Ratio-9.6475.68450.7526.15Price / Sales106.4587.011,800.32125.53Price / CashN/A85.2637.6261.28Price / Book-1.868.977.226.36Net Income-$10.13M$355.94M$808.30M$270.97M7 Day Performance12.41%-1.25%-0.63%0.36%1 Month Performance58.47%7.52%6.12%6.37%1 Year Performance68.25%80.92%24,153.40%28.46% OneMedNet Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONMDOneMedNet0.865 of 5 stars$1.06-0.9%N/A+70.1%$48.86M$459K-9.642Positive NewsMXCTMaxCyte3.716 of 5 stars$1.48+2.1%$7.00+373.0%-59.8%$154.58M$38.63M-3.4480News CoverageHQIHireQuest3.541 of 5 stars$9.78-1.0%$13.00+32.9%-31.8%$139.31M$34.60M54.3365,000Positive NewsASPSAltisource Portfolio Solutions0.6206 of 5 stars$11.07-3.0%N/A+24.2%$125.36M$160.13M-2.541,160SKLZSkillz2.6787 of 5 stars$7.38+2.6%$15.00+103.3%+29.2%$125.33M$95.47M-1.76650TDICDreamlandN/A$3.91-1.5%N/AN/A$119.10MN/A0.0015Positive NewsGap UpCTWCTW CaymanN/A$1.92+1.1%N/AN/A$118.56MN/A0.00272XBPXBP GlobalN/A$1.01+3.0%N/A-30.1%$115.19M$142.77M0.001,450RSSSResearch Solutions4.016 of 5 stars$3.50+3.9%N/A+38.5%$109.39M$44.62M-25.00130High Trading VolumeARAIArrive AIN/A$3.29+1.2%N/AN/A$107.33MN/A0.007News CoveragePositive NewsGap UpHigh Trading VolumeAMWLAmerican Well3.1955 of 5 stars$6.58+0.3%$9.17+39.3%-37.6%$105.96M$254.36M-0.821,040Positive News Related Companies and Tools Related Companies MaxCyte Alternatives HireQuest Alternatives Altisource Portfolio Solutions Alternatives Skillz Alternatives Dreamland Alternatives CTW Cayman Alternatives XBP Global Alternatives Research Solutions Alternatives Arrive AI Alternatives American Well Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ONMD) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OneMedNet Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share OneMedNet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.